Pershing Square, Valeant Pharmaceuticals International And Allergan Inc. Settle Pending Litigation Before The Delaware Court Of Chancery

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK & LAVAL, Quebec--(BUSINESS WIRE)--Pershing Square Capital Management, L.P. (“Pershing Square”) and Valeant Pharmaceuticals International, Inc. (NYSE:VRX) (TSX:VRX) (“Valeant”) announced an agreement with Allergan, Inc. (NYSE:AGN) (“Allergan”) to settle pending litigation before the Delaware Court of Chancery.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC